THE USE OF GENE EXPRESSION PROFILING AS A BIOMARKER FOR ASSESSING THE EFFICACY OF HDAC INHIBITOR TREATMENT IN NEURODEGENERATIVE CONDITIONS

摘要

The present invention relates to methods, arrays, and kits for identifying Alzheimer's disease phenotype and for assessing the efficacy of putative AD therapies. In some aspects provided, is a method of identifying the presence of an Alzheimer's disease phenotype in a subject comprising: performing an assay to measure an expression pattern of at least one Alzheimer's associated gene.